Contemporary radiotherapy: present and future
Oncology care is increasingly a multidisciplinary endeavour, and radiation therapy
continues to have a key role across the disease spectrum in nearly every cancer. However …
continues to have a key role across the disease spectrum in nearly every cancer. However …
Safety and survival rates associated with ablative stereotactic radiotherapy for patients with oligometastatic cancer: a systematic review and meta-analysis
Importance The oligometastatic paradigm postulates that patients with a limited number of
metastases can be treated with ablative local therapy to each site of disease with curative …
metastases can be treated with ablative local therapy to each site of disease with curative …
Management of salivary gland malignancy: ASCO guideline
JL Geiger, N Ismaila, B Beadle, JJ Caudell… - Journal of Clinical …, 2021 - ascopubs.org
PURPOSE To provide evidence-based recommendations for practicing physicians and
other healthcare providers on the management of salivary gland malignancy. METHODS …
other healthcare providers on the management of salivary gland malignancy. METHODS …
[HTML][HTML] Cancer of unknown primary: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up☆
A Krämer, T Bochtler, C Pauli, G Baciarello… - Annals of …, 2023 - annalsofoncology.org
CUP accounts for< 5% of cancers but, because of its high mortality rate, its relative
contribution to cancer deaths is higher. 1 The incidence of CUP has been declining …
contribution to cancer deaths is higher. 1 The incidence of CUP has been declining …
[HTML][HTML] The abscopal effect: a review of pre-clinical and clinical advances
Radiotherapy has been used for more than a hundred years to cure or locally control tumors.
Regression of tumors outside of the irradiated field was occasionally observed and is known …
Regression of tumors outside of the irradiated field was occasionally observed and is known …
Appropriate use criteria for prostate-specific membrane antigen PET imaging
Prostate cancer is the most common cancer diagnosis in men in the United States and a
leading cause of cancer-related morbidity and mortality (1). It can exist along a wide …
leading cause of cancer-related morbidity and mortality (1). It can exist along a wide …
Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer …
Background Most patients with metastatic cancer eventually develop resistance to systemic
therapy, with some having limited disease progression (ie, oligoprogression). We aimed to …
therapy, with some having limited disease progression (ie, oligoprogression). We aimed to …
Checkpoint inhibitors in combination with stereotactic body radiotherapy in patients with advanced solid tumors: the CHEERS phase 2 randomized clinical trial
Importance Although immune checkpoint inhibitors (ICIs) targeting programmed cell death 1
(PD-1) and PD-1 ligand 1 have improved the outcome for many cancer types, the majority of …
(PD-1) and PD-1 ligand 1 have improved the outcome for many cancer types, the majority of …
The oligometastatic spectrum in the era of improved detection and modern systemic therapy
Metastases remain the leading cause of cancer-related mortality. The oligometastasis
hypothesis postulates that a spectrum of metastatic spread exists and that some patients …
hypothesis postulates that a spectrum of metastatic spread exists and that some patients …
ESTRO ACROP guidelines for external beam radiotherapy of patients with uncomplicated bone metastases
J van der Velden, J Willmann, M Spałek… - Radiotherapy and …, 2022 - Elsevier
After liver and lungs, bone is the third most common metastatic site (Nystrom et al., 1977).
Almost all malignancies can metastasize to the skeleton but 80% of bone metastases …
Almost all malignancies can metastasize to the skeleton but 80% of bone metastases …